1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 22 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2001Aortico-atrial fistula secondary to bacterial endocarditisFarouque, H.; Worthley, S.; Yeend, R.
2005Systemic inflammatory markers in acute coronary syndrome: association with cardiovascular risk factors and effect of early lipid loweringMeredith, I.; Plunkett, J.; Worthley, S.; Hope, S.; Cameron, J.
2006Arterial remodeling correlates positively with serological evidence of inflammation in patients with chronic stable angina pectorisWorthley, S.; Farouque, H.; Cameron, J.; Meredith, I.
2002Time course of plasma adhesion molecules in acute coronary syndromesHope, S.; Meredith, I.; Farouque, H.; Worthley, S.; Plunkett, J.; Balazs, N.
2004Left atrial myxoma: magnet or echo?Roberts-Thomson, K.; Teo, K.; Stuklis, R.; Worthley, S.
2006The RADI™ PressureWire® high-sensitivity thermistor and culprit lesion temperature in patients with acute coronary syndromesWorthley, S.; Farouque, H.; Worthley, M.; Baldi, M.; Chew, D.; Meredith, I.
2005Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imagingCorti, R.; Fuster, V.; Fayad, Z.; Worthley, S.; Helft, G.; Chaplin, W.; Muntwyler, J.; Viles-Gonzalez, J.; Weinberger, J.; Smith, D.; Mizsei, G.; Badimon, J.
2010Long-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trialMeredith, I.; Worthley, S.; Whitbourn, R.; Walters, D.; McClean, D.; Ormiston, J.; Horrigan, M.; Wilkins, G.; Hendriks, R.; Matsis, P.; Muller, D.; Cutlip, D.
2013The innocent bystander: papillary fibroelastomaLi, A.; Azarisman, S.; Teo, K.; Worthley, M.; Sidharta, S.; Glenie, T.; Samaraie, L.; Chuah, S.; Bailie, T.; Stuklis, R.; Worthley, S.
2009Left ventricular mass and volume with Telmisartan, Ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET])Cowan, B.; Young, A.; Anderson, C.; Doughty, R.; Krittayaphong, R.; Lonn, E.; Marwick, T.; Reid, C.; Sanderson, J.; Schmieder, R.; Teo, K.; Wadham, A.; Worthley, S.; Yu, C.; Yusuf, S.; Jennings, G.

Discover